Avidity Biosciences
RNAM
#1871
Rank
A$15.77 B
Marketcap
A$102.14
Share price
0.00%
Change (1 day)
117.14%
Change (1 year)

Market capitalization of Avidity Biosciences (RNAM)

Market cap: A$15.77 Billion

As of May 2026 Avidity Biosciences has a market cap of A$15.77 Billion. This makes Avidity Biosciences the world's 1871th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences in 2026

End of year Market Cap

Year Marketcap Change
2026A$15.77 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
A$207.04 B 1,212.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$144.61 B 816.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$2.48 B-84.23%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
A$8.00 B-49.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.36 B-97.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.15 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$15.33 B-2.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$5.36 B-65.99%๐Ÿ‡บ๐Ÿ‡ธ USA